HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,394 | -75.3% | 6,581 | -71.5% | 0.05% | -72.5% |
| Q2 2022 | $1,016,000 | +0.7% | 23,084 | -8.7% | 0.17% | -1.7% |
| Q1 2022 | $1,009,000 | +107.6% | 25,295 | +74.1% | 0.17% | +480.0% |
| Q4 2021 | $486,000 | +1.0% | 14,526 | +22.9% | 0.03% | -67.4% |
| Q3 2021 | $481,000 | -44.0% | 11,823 | -42.6% | 0.09% | -19.3% |
| Q1 2021 | $859,000 | -38.6% | 20,593 | -37.2% | 0.11% | -37.7% |
| Q4 2020 | $1,400,000 | +6.8% | 32,782 | -34.3% | 0.18% | +9.6% |
| Q3 2020 | $1,311,000 | +498.6% | 49,879 | +511.1% | 0.17% | +496.4% |
| Q2 2020 | $219,000 | +313.2% | 8,162 | +176.0% | 0.03% | +300.0% |
| Q1 2020 | $53,000 | -92.6% | 2,957 | -92.7% | 0.01% | -94.1% |
| Q4 2019 | $719,000 | – | 40,532 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |